These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 20223018)

  • 21. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.
    Falchetti M; Lupi R; Rizzolo P; Ceccarelli K; Zanna I; Calò V; Tommasi S; Masala G; Paradiso A; Gulino A; Giannini G; Russo A; Palli D; Ottini L
    Breast Cancer Res Treat; 2008 Jul; 110(1):161-7. PubMed ID: 17661168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer susceptibility genes.
    Lubinski J; Korzen M; Gorski B; Cybulski C; Debniak T; Jakubowska A; Medrek K; Matyjasik J; Huzarski T; Byrski T; Gronwald J; Masojc B; Lener M; Szymanska A; Szymanska-Pasternak J; Fernandez PS; Wokolorczyk D; Piegat A; Ucinski M; Domagala P; Kladny J; Gorecka B; Scott R; Narod S
    J BUON; 2007 Sep; 12 Suppl 1():S23-9. PubMed ID: 17935274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
    Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
    Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer.
    Gaj P; Kluska A; Nowakowska D; Bałabas A; Piątkowska M; Dabrowska M; Niwińska A; Ostrowski J
    Fam Cancer; 2012 Dec; 11(4):623-8. PubMed ID: 22864640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer predisposing alleles in Poland.
    Górski B; Cybulski C; Huzarski T; Byrski T; Gronwald J; Jakubowska A; Stawicka M; Gozdecka-Grodecka S; Szwiec M; Urbański K; Mituś J; Marczyk E; Dziuba J; Wandzel P; Surdyka D; Haus O; Janiszewska H; Debniak T; Tołoczko-Grabarek A; Medrek K; Masojć B; Mierzejewski M; Kowalska E; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2005 Jul; 92(1):19-24. PubMed ID: 15980987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online.
    Csokay B; Tihomirova L; Stengrevics A; Sinicka O; Olah E
    Hum Mutat; 1999; 14(1):92. PubMed ID: 10447273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia.
    Plakhins G; Irmejs A; Gardovskis A; Subatniece S; Rozite S; Bitina M; Keire G; Purkalne G; Teibe U; Trofimovics G; Miklasevics E; Gardovskis J
    BMC Med Genet; 2011 Oct; 12():147. PubMed ID: 22032251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel.
    Laitman Y; Simeonov M; Herskovitz L; Kushnir A; Shimon-Paluch S; Kaufman B; Zidan J; Friedman E
    Breast Cancer Res Treat; 2012 Jun; 133(3):1153-7. PubMed ID: 22399190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genotyping of BRCA1, BRCA2 and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips].
    Nasedkina TV; Gromyko OE; Emel'ianova MA; Ignatova EO; Kazubskaia TP; Portnoĭ SM; Zasedatelev AS; Liubchenko LN
    Mol Biol (Mosk); 2014; 48(2):243-50. PubMed ID: 25850293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.
    Lavie O; Narod S; Lejbkowicz F; Dishon S; Goldberg Y; Gemer O; Rennert G
    Ann Oncol; 2011 Apr; 22(4):964-966. PubMed ID: 20924075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Second Primary Thyroid Cancer in Women with Breast Cancer.
    Cieszyńska M; Kluźniak W; Wokołorczyk D; Cybulski C; Huzarski T; Gronwald J; Falco M; Dębniak T; Jakubowska A; Derkacz R; Marciniak W; Lener M; Woronko K; Mocarz D; Baszuk P; Bryśkiewicz M; Narod SA; Lubiński J
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland.
    Jasiewicz A; Rudnicka H; Kluźniak W; Gronwald W; Kluz T; Cybulski C; Jakubowska A; Lubiński J; Gronwald J
    Hered Cancer Clin Pract; 2022 Apr; 20(1):12. PubMed ID: 35382848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.
    Sokolenko AP; Rozanov ME; Mitiushkina NV; Sherina NY; Iyevleva AG; Chekmariova EV; Buslov KG; Shilov ES; Togo AV; Bit-Sava EM; Voskresenskiy DA; Chagunava OL; Devilee P; Cornelisse C; Semiglazov VF; Imyanitov EN
    Fam Cancer; 2007; 6(3):281-6. PubMed ID: 17333477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
    Van Der Looij M; Szabo C; Besznyak I; Liszka G; Csokay B; Pulay T; Toth J; Devilee P; King MC; Olah E
    Int J Cancer; 2000 Jun; 86(5):737-40. PubMed ID: 10797299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
    Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
    Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
    Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland.
    Bąk A; Janiszewska H; Junkiert-Czarnecka A; Heise M; Pilarska-Deltow M; Laskowski R; Pasińska M; Haus O
    Hered Cancer Clin Pract; 2014 Apr; 12(1):10. PubMed ID: 24713400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.